v3.26.1
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
 3 Months Ended 9 Months Ended
Apr. 30, 2026
Apr. 30, 2025
Apr. 30, 2026
Apr. 30, 2025
Operating activities        
Net loss $ (624,000) $ (580,000) $ (1,873,000) $ (2,067,000)
Adjustments to reconcile net loss to net cash used in operating activities:        
Share-based compensation 55,000 33,000 147,000 117,000
Depreciation     2,000 2,000
Changes in operating assets and liabilities:        
Accounts receivable     232,000 11,000
Inventories     (91,000) (75,000)
Prepaid expenses     6,000 14,000
Interest on note payable     291,000 200,000
Accounts payable and accrued liabilities     (38,000) 239,000
Net cash used in operating activities     (1,324,000) (1,559,000)
Financing activities        
Net proceeds from private placement     1,003,000
Net proceeds from note payable to related parties     970,000 1,750,000
Net cash provided by financing activities     1,973,000 1,750,000
Net increase in cash, cash equivalents, and restricted cash     649,000 191,000
Cash, cash equivalents, and restricted cash at beginning of period     409,000 424,000
Cash, cash equivalents, and restricted cash at end of period 1,058,000 615,000 1,058,000 615,000
Reconciliation of cash, cash equivalents, and restricted cash to the condensed consolidated balance sheets        
Cash and cash equivalents 983,000 540,000 983,000 540,000
Restricted cash 75,000 75,000 75,000 75,000
Total cash, cash equivalents and restricted cash $ 1,058,000 $ 615,000 $ 1,058,000 $ 615,000